Litigation
Celgene Corp. v. Sun Pharmaceutical Industries, Inc.
settled2:21-cv-01734
Auto-generating section 1 of 4: Case overview & background…
Each section takes ~30-60s with web-search grounding. Keep this tab open — sections will fill in below as they complete.
- Court
- D.N.J.
- Filed
- 2021-02-02
- Terminated
- 2021-06-21
Patents at issue (1)
Plaintiffs (1)
Defendants (1)
Summary
Celgene sued Sun Pharmaceutical Industries and others in a D.N.J. ANDA action involving ANDA No. 211846; the case settled on June 21, 2021, with limited quantities after March 2022 and unlimited from January 31, 2026.
Case overview & background
Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Key legal developments & outcome
Major rulings, motions, claim construction, settlements, and the present posture or final disposition.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Plaintiff representatives
Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Defendant representatives
Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).